• 3051 Citations
20012024

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

  • 3051 Citations
  • 60 Article
  • 25 Review article
  • 3 Comment/debate
  • 1 Short survey
2020

Pharmacokinetics of doxorubicin following concomitant intravenous administration of olaratumab (IMC-3G3) to patients with advanced soft tissue sarcoma

Villalobos, V. M., Mo, G., Agulnik, M., Pollack, S. M., Rushing, D. A., Singh, A., Van Tine, B. A., McNaughton, R., Decker, R. L., Zhang, W., Shahir, A. & Cronier, D. M., Feb 1 2020, In : Cancer medicine. 9, 3, p. 882-893 12 p.

Research output: Contribution to journalArticle

Open Access
2019

A phase II clinical study of 13-deoxy, 5-iminodoxorubicin (GPX-150) with metastatic and unresectable soft tissue sarcoma

Van Tine, B. A., Agulnik, M., Olson, R. D., Walsh, G. M., Klausner, A., Frank, N. E., Talley, T. T. & Milhem, M. M., Jun 2019, In : Cancer medicine. 8, 6, p. 2994-3003 10 p.

Research output: Contribution to journalArticle

Open Access

Ectopic hamartomatous thymoma in an immunocompromised male

Waters, D., Obeidin, F., Alexiev, B. A., Rao, M. S., Peabody, T. D., Agulnik, M. & Yeldandi, A., Sep 2019, In : Pathology Research and Practice. 215, 9, 152497.

Research output: Contribution to journalArticle

Piloting a financial counseling intervention for patients with cancer receiving chemotherapy

Kircher, S. M., Yarber, J., Rutsohn, J., Guevara, Y., Lyleroehr, M., Jackson, H. A., Walradt, J., Desai, B., Mulcahy, M., Kalyan, A., Benson, A. B., Agulnik, M., Mohindra, N., DeSouza, J. & Garcia, S. F., Mar 1 2019, In : Journal of oncology practice. 15, 3, p. E202-E210

Research output: Contribution to journalArticle

2 Scopus citations

Randomized double-blind phase II study of regorafenib in patients with metastatic osteosarcoma

Davis, L. E., Bolejack, V., Ryan, C. W., Ganjoo, K. N., Loggers, E. T., Chawla, S., Agulnik, M., Livingston, M. B., Reed, D., Keedy, V., Rushing, D., Okuno, S., Reinke, D. K., Riedel, R. F., Attia, S., Mascarenhas, L. & Maki, R. G., Jan 1 2019, In : Journal of Clinical Oncology. 37, 16, p. 1424-1431 8 p.

Research output: Contribution to journalArticle

14 Scopus citations
2018

Antitumor activity of nivolumab in recurrent and metastatic nasopharyngeal carcinoma: An international, multicenter study of the mayo clinic phase 2 consortium (NCI-9742)

Ma, B. B. Y., Lim, W. T., Goh, B. C., Hui, E. P., Lo, K. W., Pettinger, A., Foster, N. R., Riess, J. W., Agulnik, M., Chang, A. Y. C., Chopra, A., Kish, J. A., Chung, C. H., Adkins, D. R., Cullen, K. J., Gitlitz, B. J., Lim, D. W., To, K. F., Chan, K. C. A., Lo, Y. M. D. & 5 others, King, A. D., Erlichman, C., Yin, J., Costello, B. A. & Chan, A. T. C., Jan 1 2018, In : Journal of Clinical Oncology. 36, 14, p. 1412-1418 7 p.

Research output: Contribution to journalArticle

69 Scopus citations

A phase II, multicenter study of the EZH2 inhibitor tazemetostat in adults: Epithelioid sarcoma cohort (NCT02601950)

Gounder, M., Schöffski, P., Villalobos, V., Cote, G., Chugh, R., Chen, T. W. W., Jahan, T., Loggers, E. T., Italiano, A., Gupta, A., Agulnik, M., Attia, S., Jones, R. L., van Tine, B. A., Demetri, G. D. D., Roche, M., Sapir, I., Daigle, S., Clawson, A. & Stacchiotti, S., Oct 1 2018, In : Annals of oncology : official journal of the European Society for Medical Oncology. 29, p. viii581-viii582

Research output: Contribution to journalArticle

Open Access

A phase II, multicenter study of the EZH2 inhibitor tazemetostat in adults (rhabdoid tumor cohort) (NCT02601950)

Jones, R. L., Blay, J. Y., Agulnik, M., Chugh, R., Mir, O., Italiano, A., Thomas, D., Gupta, A., Jahan, T., Cote, G., Villalobos, V., Demetri, G. D. D., Roche, M., Sapir, I., Daigle, S., Clawson, A. & Gounder, M., Oct 1 2018, In : Annals of oncology : official journal of the European Society for Medical Oncology. 29, p. viii580-viii581

Research output: Contribution to journalArticle

Open Access

A phase II study of pazopanib with oral topotecan in patients with metastatic osteosarcoma

van Tine, B. A., Mohindra, N., Milhem, M., Attia, S., Robinson, S. I., Rademaker, A., Okuno, S. H. & Agulnik, M., Oct 1 2018, In : Annals of oncology : official journal of the European Society for Medical Oncology. 29, p. viii579

Research output: Contribution to journalArticle

Open Access

Epithelioid Hemangioendothelioma: Update on Diagnosis and Treatment

Rosenberg, A. & Agulnik, M., Apr 1 2018, In : Current treatment options in oncology. 19, 4, 19.

Research output: Contribution to journalComment/debate

15 Scopus citations

Growing Role of Regorafenib in the Treatment of Patients with Sarcoma

Agulnik, M. & Attia, S., Aug 1 2018, In : Targeted Oncology. 13, 4, p. 417-422 6 p.

Research output: Contribution to journalReview article

2 Scopus citations

KS in the era of HAART: A single institutional retrospective review

Sankar, K., Foster, K., Achenbach, C. & Agulnik, M., Oct 1 2018, In : Annals of oncology : official journal of the European Society for Medical Oncology. 29, p. viii590

Research output: Contribution to journalArticle

Open Access

Molecular characterization of epithelioid sarcoma (ES) tumors derived from patients enrolled in a phase II study of tazemetostat (NCT02601950)

Daigle, S., Stacchiotti, S., Schöffski, P., Villalobos, V., Cote, G., Chugh, R., Chen, T. W. W., Jahan, T., Loggers, E. T., Italiano, A., Gupta, A., Agulnik, M., Attia, S., Jones, R. L., van Tine, B. A., Demetri, G. D. D., Clawson, A., Roche, M., Blakemore, S. & Gounder, M., Oct 1 2018, In : Annals of oncology : official journal of the European Society for Medical Oncology. 29, p. viii670

Research output: Contribution to journalArticle

Open Access

Multicenter, open-label phase II study of daily oral regorafenib for chemotherapy-refractory, metastatic and locally advanced angiosarcoma

Agulnik, M., van Tine, B. A., Attia, S., Rademaker, A., Milhem, M. & Okuno, S. H., Oct 1 2018, In : Annals of oncology : official journal of the European Society for Medical Oncology. 29, p. viii592

Research output: Contribution to journalArticle

Open Access

Perceptions of clinical trial enrollment in patients with bone and soft tissue sarcoma

Rosenberg, A., Kircher, S., Hahn, E., Rademaker, A., Bilimoria, K., Wayne, J. D. & Agulnik, M., Oct 1 2018, In : Annals of oncology : official journal of the European Society for Medical Oncology. 29, p. viii587-viii588

Research output: Contribution to journalArticle

Open Access

Posterior reversible encephalopathy syndrome and takotsubo cardiomyopathy associated with lenvatinib therapy for thyroid cancer: A case report and review

Chae, Y. K., Chiec, L., Adney, S. K., Waitzman, J., Costa, R., Carneiro, B., Matsangou, M., Agulnik, M., Kopp, P. & Giles, F., Jun 15 2018, In : Oncotarget. 9, 46, p. 28281-28289 9 p.

Research output: Contribution to journalArticle

1 Scopus citations
2017

A phase II study of tivozanib in patients with metastatic and nonresectable soft-tissue sarcomas

Agulnik, M., Costa, R. L. B., Milhem, M., Rademaker, A. W., Prunder, B. C., Daniels, D., Rhodes, B. T., Humphreys, C., Abbinanti, S., Nye, L., Cehic, R., Polish, A., Vintilescu, C., McFarland, T., Skubitz, K., Robinson, S., Okuno, S. & Van Tine, B. A., Jan 1 2017, In : Annals of Oncology. 28, 1, p. 121-127 7 p.

Research output: Contribution to journalArticle

8 Scopus citations

Bone cancer, version 2.2017 featured updates to the NCCN guidelines

Biermann, J. S., Chow, W., Reed, D. R., Lucas, D., Adkins, D. R., Agulnik, M., Benjamin, R. S., Brigman, B., Budd, G. T., Curry, W. T., Didwania, A., Fabbri, N., Hornicek, F. J., Kuechle, J. B., Lindskog, D., Mayerson, J., McGarry, S. V., Million, L., Morris, C. D., Movva, S. & 11 others, O'Donnell, R. J., Randall, R. L., Rose, P., Santana, V. M., Satcher, R. L., Schwartz, H., Siegel, H. J., Thornton, K., Villalobos, V., Bergman, M. A. & Scavone, J. L., Feb 1 2017, In : JNCCN Journal of the National Comprehensive Cancer Network. 15, 2, p. 155-167 13 p.

Research output: Contribution to journalArticle

54 Scopus citations

Doxorubicin plus evofosfamide versus doxorubicin alone in locally advanced, unresectable or metastatic soft-tissue sarcoma (TH CR-406/SARC021): an international, multicentre, open-label, randomised phase 3 trial

Tap, W. D., Papai, Z., Van Tine, B. A., Attia, S., Ganjoo, K. N., Jones, R. L., Schuetze, S., Reed, D., Chawla, S. P., Riedel, R. F., Krarup-Hansen, A., Toulmonde, M., Ray-Coquard, I., Hohenberger, P., Grignani, G., Cranmer, L. D., Okuno, S., Agulnik, M., Read, W., Ryan, C. W. & 8 others, Alcindor, T., del Muro, X. F. G., Budd, G. T., Tawbi, H., Pearce, T., Kroll, S., Reinke, D. K. & Schöffski, P., Aug 2017, In : The Lancet Oncology. 18, 8, p. 1089-1103 15 p.

Research output: Contribution to journalArticle

60 Scopus citations

Olaratumab for advanced soft tissue sarcoma

Tobias, A., O’brien, M. P. & Agulnik, M., Jul 3 2017, In : Expert Review of Clinical Pharmacology. 10, 7, p. 699-705 7 p.

Research output: Contribution to journalArticle

8 Scopus citations

Stereotactic radiosurgery for brain metastases from primary head and neck carcinomas: a retrospective analysis

Patel, R. A., Bell, J. B., Kim, T., Agulnik, M., Chandler, J. P., Mittal, B. B. & Kruser, T. J., Aug 1 2017, In : Journal of Neuro-Oncology. 134, 1, p. 197-203 7 p.

Research output: Contribution to journalArticle

2 Scopus citations

Targeted Therapy in Head and Neck Cancer: An Update on Current Clinical Developments in Epidermal Growth Factor Receptor-Targeted Therapy and Immunotherapies

Moreira, J., Tobias, A., O’Brien, M. P. & Agulnik, M., May 1 2017, In : Drugs. 77, 8, p. 843-857 15 p.

Research output: Contribution to journalReview article

21 Scopus citations

Toxicity profile of approved anti-PD-1 monoclonal antibodies in solid tumors: A systematic review and meta-analysis of randomized clinical trials

Costa, R., Carneiro, B. A., Agulnik, M., Rademaker, A. W., Pai, S. G., Villaflor, V. M., Cristofanilli, M., Sosman, J. A. & Giles, F. J., Jan 1 2017, In : Oncotarget. 8, 5, p. 8910-8920 11 p.

Research output: Contribution to journalReview article

59 Scopus citations
2016

Dose-escalation study of a second-generation non-ansamycin HSP90 inhibitor, onalespib (AT13387), in combination with imatinib in patients with metastatic gastrointestinal stromal tumour

Wagner, A. J., Agulnik, M., Heinrich, M. C., Mahadevan, D., Riedel, R. F., Von Mehren, M., Trent, J., Demetri, G. D., Corless, C. L., Yule, M., Lyons, J. F., Oganesian, A. & Keer, H., Jul 1 2016, In : European Journal of Cancer. 61, p. 94-101 8 p.

Research output: Contribution to journalArticle

17 Scopus citations

Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trial

Tap, W. D., Jones, R. L., Van Tine, B. A., Chmielowski, B., Elias, A. D., Adkins, D., Agulnik, M., Cooney, M. M., Livingston, M. B., Pennock, G., Hameed, M. R., Shah, G. D., Qin, A., Shahir, A., Cronier, D. M., Ilaria, R., Conti, I., Cosaert, J. & Schwartz, G. K., Jul 30 2016, In : The Lancet. 388, 10043, p. 488-497 10 p.

Research output: Contribution to journalArticle

332 Scopus citations

Ontuxizumab: USAN; Rec INN

Tobias, A. & Agulnik, M., Aug 2016, In : Drugs of the Future. 41, 8, p. 471-476 6 p.

Research output: Contribution to journalArticle

Phase II study of MLN8237 (Alisertib) in advanced/ metastatic sarcoma

Dickson, M. A., Mahoney, M. R., Tap, W. D., D'Angelo, S. P., Keohan, M. L., Van Tine, B. A., Agulnik, M., Horvath, L. E., Nair, J. S. & Schwartz, G. K., Jan 1 2016, In : Annals of Oncology. 27, 10, p. 1855-1860 6 p.

Research output: Contribution to journalArticle

40 Scopus citations

PICASSO III: A phase III, placebo-controlled study of doxorubicin with or without palifosfamide in patients with metastatic soft tissue sarcoma

Ryan, C. W., Merimsky, O., Agulnik, M., Blay, J. Y., Schuetze, S. M., Van Tine, B. A., Jones, R. L., Elias, A. D., Choy, E., Alcindor, T., Keedy, V. L., Reed, D. R., Taub, R. N., Italiano, A., Del Muro, X. G., Judson, I. R., Buck, J. Y., Lebel, F., Lewis, J. J., Maki, R. G. & 1 others, Schöffski, P., Nov 10 2016, In : Journal of Clinical Oncology. 34, 32, p. 3898-3905 8 p.

Research output: Contribution to journalArticle

70 Scopus citations

Spotlight on lenvatinib in the treatment of thyroid cancer: Patient selection and perspectives

Costa, R., Carneiro, B. A., Chandra, S., Pai, S. G., Chae, Y. K., Kaplan, J. B., Garrett, H. B., Agulnik, M., Kopp, P. A. & Giles, F. J., Feb 29 2016, In : Drug Design, Development and Therapy. 10, p. 873-884 12 p.

Research output: Contribution to journalReview article

21 Scopus citations
2015

A phase IB/IL study of gemcitabine and docetaxel in combination with pazopanib for the neoadjuvant treatment of soft tissue sarcomas

Munhoz, R. R., D’Angelo, S. P., Gounder, M. M., Keohan, M. L., Chi, P., Carvajal, R. D., Singer, S., Crago, A. M., Landa, J., Healey, J. H., Qin, L. X., Hameed, M., Ezeoke, M., Singh, A. S., Agulnik, M., Chmielowski, B., Luke, J. J., Vantine, B. A., Schwartz, G. K., Tap, W. D. & 1 others, Dickson, M. A., Oct 8 2015, In : Oncologist. 20, 11, p. 1245-1246 2 p.

Research output: Contribution to journalArticle

17 Scopus citations

Effect of induction chemotherapy on swallow physiology and saliva production in patients with head and neck cancer: A pilot study

Mittal, B. B., Pauloski, B. R., Rademaker, A. W., Discekici-Harris, M., Helenowski, I. B., Mellot, A., Agulnik, M. & Logemann, J. A., Apr 1 2015, In : Head and Neck. 37, 4, p. 567-572 6 p.

Research output: Contribution to journalArticle

7 Scopus citations

Targeted therapies in advanced differentiated thyroid cancer

Carneiro, R. M., Carneiro, B. A., Agulnik, M., Kopp, P. A. & Giles, F. J., Sep 1 2015, In : Cancer Treatment Reviews. 41, 8, p. 690-698 9 p.

Research output: Contribution to journalReview article

38 Scopus citations

Targeted therapy and promising novel agents for the treatment of advanced soft tissue sarcomas

Mohindra, N. A. & Agulnik, M., Aug 9 2015, In : Expert Opinion on Investigational Drugs. 24, 11, p. 1409-1418 10 p.

Research output: Contribution to journalReview article

3 Scopus citations

Whole-field sequential intensity-modulated radiotherapy for local-regional advanced head-and-neck squamous cell carcinoma

Refaat, T., Choi, M., Thomas, T. O., Bacchus, I., Agulnik, M., Pelzer, H. J., Mellott, A. L., Rademaker, A. W., Liu, D., Sathiaseelan, V. & Mittal, B. B., Jan 1 2015, In : American Journal of Clinical Oncology: Cancer Clinical Trials. 38, 6, p. 588-594 7 p.

Research output: Contribution to journalArticle

2 Scopus citations
2014

Assessment of multimodality therapy use for extremity sarcoma in the United States

Sherman, K. L., Wayne, J. D., Chung, J., Agulnik, M., Attar, S., Hayes, J. P., Laskin, W. B., Peabody, T. D., Bentrem, D. J., Pollock, R. E. & Bilimoria, K. Y., Apr 2014, In : Journal of surgical oncology. 109, 5, p. 395-404 10 p.

Research output: Contribution to journalArticle

30 Scopus citations

Examination of national lymph node evaluation practices for adult extremity soft tissue sarcoma

Sherman, K. L., Kinnier, C. V., Farina, D. A., Wayne, J. D., Laskin, W. B., Agulnik, M., Attar, S., Hayes, J. P., Peabody, T. & Bilimoria, K. Y., Nov 1 2014, In : Journal of surgical oncology. 110, 6, p. 682-688 7 p.

Research output: Contribution to journalArticle

21 Scopus citations

Occult primary, version 3.2014; Featured updates to the NCCN guidelines

Ettinger, D. S., Handorf, C. R., Agulnik, M., Bowles, D. W., Cates, J. M., Cristea, M., Dotan, E., Eaton, K. D., Fidias, P. M., Gierada, D., Weldon Gilcrease, G., Godby, K., Iyer, R., Lenzi, R., Phay, J., Rashid, A., Saltz, L., Schwab, R. B., Shulman, L. N., Smerage, J. B. & 6 others, Stevenson, M. M., Varadhachary, G. R., Zager, J. S., Zhen, W., Bergman, M. A. & Freedman-Cass, D. A., Jul 1 2014, In : JNCCN Journal of the National Comprehensive Cancer Network. 12, 7, p. 969-974 6 p.

Research output: Contribution to journalArticle

15 Scopus citations

Overview and management of dermatologic events associated with targeted therapies for medullary thyroid cancer

Lacouture, M. E., Ciccolini, K., Kloos, R. T. & Agulnik, M., Sep 1 2014, In : Thyroid. 24, 9, p. 1329-1340 12 p.

Research output: Contribution to journalReview article

17 Scopus citations

Phase III randomized trial of induction chemotherapy in patients with N2 or N3 locally advanced head and neck cancer

Cohen, E. E. W., Karrison, T. G., Kocherginsky, M., Mueller, J., Egan, R., Huang, C. H., Brockstein, B. E., Agulnik, M. B., Mittal, B. B., Yunus, F., Samant, S., Raez, L. E., Mehra, R., Kumar, P., Ondrey, F., Marchand, P., Braegas, B., Seiwert, T. Y., Villaflor, V. M., Haraf, D. J. & 1 others, Vokes, E. E., Sep 1 2014, In : Journal of Clinical Oncology. 32, 25, p. 2735-2743 9 p.

Research output: Contribution to journalArticle

248 Scopus citations

Targeted treatment of head and neck squamous-cell carcinoma: Potential of lapatinib

Gandhi, M. D. & Agulnik, M., Feb 13 2014, In : OncoTargets and Therapy. 7, p. 245-251 7 p.

Research output: Contribution to journalReview article

7 Scopus citations
5 Scopus citations
2013

Afatinib: Emerging next-generation tyrosine kinase inhibitor for NSCLC

Nelson, V., Ziehr, J., Agulnik, M. & Johnson, M., Mar 20 2013, In : OncoTargets and Therapy. 6, p. 135-143 9 p.

Research output: Contribution to journalReview article

67 Scopus citations

An open-label, multicenter, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas

Agulnik, M., Yarber, J. L., Okuno, S. H., von Mehren, M., Jovanovic, B. D., Brockstein, B. E., Evens, A. M. & Benjamin, R. S., Jan 1 2013, In : Annals of Oncology. 24, 1, p. 257-263 7 p., mds237.

Research output: Contribution to journalArticle

182 Scopus citations

A phase II study of tasisulam sodium (LY573636 sodium) as second-line or third-line treatment for patients with unresectable or metastatic soft tissue sarcoma

Ryan, C. W., Matias, C., Agulnik, M., Lopez-Pousa, A., Williams, C., De Alwis, D. P., Kaiser, C., Miller, M. A., Ermisch, S., Ilaria, R. & Keohan, M. L., Feb 1 2013, In : Investigational New Drugs. 31, 1, p. 145-151 7 p.

Research output: Contribution to journalArticle

5 Scopus citations

Bone Cancer: Clinical practice guidelines in oncology

Sybil Biermann, J., Adkins, D. R., Agulnik, M., Benjamin, R. S., Brigman, B., Butrynski, J. E., Cheong, D., Chow, W., Curry, W. T., Frassica, D. A., Frassica, F. J., Hande, K. R., Hornicek, F. J., Jones, R. L., Mayerson, J., McGarry, S. V., McGrath, B., Morris, C. D., O'donnell, R. J., Lor Randall, R. & 6 others, Santana, V. M., Satcher, R. L., Siegel, H. J., Von Mehren, M., Bergman, M. A. & Sundar, H., Jun 1 2013, In : JNCCN Journal of the National Comprehensive Cancer Network. 11, 6, p. 688-723 36 p.

Research output: Contribution to journalArticle

60 Scopus citations

Cixutumumab and temsirolimus for patients with bone and soft-tissue sarcoma: A multicentre, open-label, phase 2 trial

Schwartz, G. K., Tap, W. D., Qin, L. X., Livingston, M. B., Undevia, S. D., Chmielowski, B., Agulnik, M., Schuetze, S. M., Reed, D. R., Okuno, S. H., Ludwig, J. A., Keedy, V., Rietschel, P., Kraft, A. S., Adkins, D., Van Tine, B. A., Brockstein, B., Yim, V., Bitas, C., Abdullah, A. & 8 others, Antonescu, C. R., Condy, M., Dickson, M. A., Vasudeva, S. D., Ho, A. L., Doyle, L. A., Chen, H. X. & Maki, R. G., Apr 1 2013, In : The Lancet Oncology. 14, 4, p. 371-382 12 p.

Research output: Contribution to journalArticle

121 Scopus citations
2 Scopus citations

Promising new molecular targeted therapies in head and neck cancer

Dorsey, K. & Agulnik, M., Mar 1 2013, In : Drugs. 73, 4, p. 315-325 11 p.

Research output: Contribution to journalArticle

53 Scopus citations
2012

Advances in adjuvant therapy of gastrointestinal stromal tumors

Adekola, K. & Agulnik, M., Aug 1 2012, In : Current oncology reports. 14, 4, p. 327-332 6 p.

Research output: Contribution to journalArticle

4 Scopus citations

Neoadjuvant use of sunitinib in locally advanced GIST with intolerance to imatinib

Svetlichnaya, J., Huyck, T. K., Wayne, J. D. & Agulnik, M., Mar 1 2012, In : Chemotherapy. 58, 1, p. 30-33 4 p.

Research output: Contribution to journalArticle

8 Scopus citations